Literature DB >> 17966030

Detection of gene expression in synovium of patients with osteoarthritis using a random sequencing method.

Takahiro Okabe1, Yoshihiro Ohmori, Akira Tanigami, Haretsugu Hishigaki, Yutaka Suzuki, Sumio Sugano, Amu Kawaguchi, Hiroyuki Nakaya, Shigeyuki Wakitani.   

Abstract

BACKGROUND: The etiology of osteoarthritis (OA) is multifactorial and current research attributes it to a complex network of biochemical factors. We attempted to identify important molecules in OA joint destruction. PATIENTS AND METHODS: Synovium was collected from 2 women with hip OA. Total RNA was extracted from the combined synovium. Messenger RNAs (mRNAs) were randomly sequenced for identification with the oligo-capping method. mRNA expression of 9 genes that were found to be frequently expressed was compared in synovium from 7 OA patients and 2 control patients with no signs of arthritis.
RESULTS: We sequenced 7,339 mRNAs in total and identified 4,247 different kinds, which were ranked in order of frequency. Fibronectin was the protein most frequently expressed (230/7,339), followed by matrix metalloproteinases (MMPs) 1 and 3. The 9 genes selected were those encoding fibronectin 1, MMP1, MMP3, tissue inhibitor of metalloproteinase 3, apolipoprotein L-I (APOL1), syndecan binding protein, insulin-like growth factor binding protein 5, heat shock protein 90, and a disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAMTS5). We investigated expression of these 9 genes in synovium from the 7 individual patients with OA. All 9 genes were expressed in OA and control synovium. Expression of MMP1 mRNA was weak in OA samples, however, while expression of ADAMTS5 and APOL1 mRNAs was weak in the controls and some of the OA samples.
INTERPRETATION: ADAMTS5 and APOL1 may have important roles in the mechanism of OA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17966030     DOI: 10.1080/17453670710014400

Source DB:  PubMed          Journal:  Acta Orthop        ISSN: 1745-3674            Impact factor:   3.717


  8 in total

1.  Immune and inflammatory pathways are involved in inherent bone marrow ossification.

Authors:  Umut Atakan Gurkan; Ryan Golden; Vipuil Kishore; Catherine P Riley; Jiri Adamec; Ozan Akkus
Journal:  Clin Orthop Relat Res       Date:  2012-09       Impact factor: 4.176

2.  The change of synovial fluid proteome in rabbit surgery-induced model of knee osteoarthritis.

Authors:  Qinglu Luo; Xi Qin; Yaxian Qiu; Lingying Hou; Ning Yang
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

3.  The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions.

Authors:  Eric E Smith; Harmit S Malik
Journal:  Genome Res       Date:  2009-03-19       Impact factor: 9.043

4.  Whole-transcriptome sequencing of knee joint cartilage from osteoarthritis patients.

Authors:  H Li; H H Yang; Z G Sun; H B Tang; J K Min
Journal:  Bone Joint Res       Date:  2019-07-05       Impact factor: 5.853

5.  Biological Effects of Phosphocitrate on Osteoarthritic Articular Chondrocytes.

Authors:  Yubo Sun; Atiya M Franklin; David R Mauerhan; Edward N Hanley
Journal:  Open Rheumatol J       Date:  2017-05-31

6.  Whole-transcriptome sequencing of knee joint cartilage from osteoarthritis patients.

Authors:  H Li; H H Yang; Z G Sun; H B Tang; J K Min
Journal:  Bone Joint Res       Date:  2019-08-02       Impact factor: 5.853

7.  Phosphocitrate is potentially a disease-modifying drug for noncrystal-associated osteoarthritis.

Authors:  Yubo Sun; David R Mauerhan; Atiya M Franklin; James Norton; Edward N Hanley; Helen E Gruber
Journal:  Biomed Res Int       Date:  2013-02-21       Impact factor: 3.411

8.  Expression of novel extracellular sulfatases Sulf-1 and Sulf-2 in normal and osteoarthritic articular cartilage.

Authors:  Shuhei Otsuki; Noboru Taniguchi; Shawn P Grogan; Darryl D'Lima; Mitsuo Kinoshita; Martin Lotz
Journal:  Arthritis Res Ther       Date:  2008-05-28       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.